Search
for
Sort by
Research 361–390 of 529
- Journal of Population Therapeutics and Clinical Pharmacology
- Alopecia Areata and Vitamin D3 Deficiency: The Potential of Calcipotriol as a Treatment
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Hidradenitis suppurativa: a new therapeutic approach for an old disease
- FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS
- Dermatolojik Problemler ve COVID-19
- Effect of Topical Gel Administration of Secretome Hypoxia Mesenchymal Stem Cells (SH-MSCs) on IL-10 and TNF- α Gene Expression (In Vivo Experimental Study in Male Rats of Wistar Strains Model of Fluconazole-Induced Alopecia)
- Hair Growth Stimulation Effect of Centipeda minima Extract: Identification of Active Compounds and Anagen-Activating Signaling Pathways
- 1310 Anti-aging effects of retinoid hydroxypinacolone retinoate on skin models
- Etiopathogenesis of Alopecia Areata
- Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia
- Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database
- Nanotecnología en Tricología: Avances Terapéuticos y Perspectivas Futuras en el Tratamiento de las Alopecias
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- 1314 Advanced age impairs self-renewal and biases fate choice of hair follicle dermal stem cells
- 1315 An Integrated model of alopecia areata biomarkers highlights both Th1/Th2 upregulation, with stronger correlations between Th2 activation and disease severity
- 1312 Nrf2 activation enhances the healing of cutaneous wounds through the activation of hair follicle stem cells
- 1311 Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- Alopecia areata
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Transcriptional Profiling in Rat Hair Follicles following Simulated Blast Insult: A New Diagnostic Tool for Traumatic Brain Injury
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata
- Increase in IL-15 levels in patients with alopecia areata
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis